BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 31393705)

  • 1. Intact-Mass Analysis Facilitating the Identification of Large Human Heart Proteoforms.
    Schaffer LV; Tucholski T; Shortreed MR; Ge Y; Smith LM
    Anal Chem; 2019 Sep; 91(17):10937-10942. PubMed ID: 31393705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Proteoform Identifications in Complex Systems Through Integration of Bottom-Up and Top-Down Data.
    Schaffer LV; Millikin RJ; Shortreed MR; Scalf M; Smith LM
    J Proteome Res; 2020 Aug; 19(8):3510-3517. PubMed ID: 32584579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoform Analysis and Construction of Proteoform Families in Proteoform Suite.
    Schaffer LV; Shortreed MR; Smith LM
    Methods Mol Biol; 2022; 2500():67-81. PubMed ID: 35657588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Top-Down Proteomics Platform Coupling Serial Size Exclusion Chromatography and Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Tucholski T; Knott SJ; Chen B; Pistono P; Lin Z; Ge Y
    Anal Chem; 2019 Mar; 91(6):3835-3844. PubMed ID: 30758949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Top-Down Proteomics of Large Proteins up to 223 kDa Enabled by Serial Size Exclusion Chromatography Strategy.
    Cai W; Tucholski T; Chen B; Alpert AJ; McIlwain S; Kohmoto T; Jin S; Ge Y
    Anal Chem; 2017 May; 89(10):5467-5475. PubMed ID: 28406609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding Proteoform Identifications in Top-Down Proteomic Analyses by Constructing Proteoform Families.
    Schaffer LV; Shortreed MR; Cesnik AJ; Frey BL; Solntsev SK; Scalf M; Smith LM
    Anal Chem; 2018 Jan; 90(2):1325-1333. PubMed ID: 29227670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mass graph-based approach for the identification of modified proteoforms using top-down tandem mass spectra.
    Kou Q; Wu S; Tolic N; Paša-Tolic L; Liu Y; Liu X
    Bioinformatics; 2017 May; 33(9):1309-1316. PubMed ID: 28453668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Proteoforms with Unknown Post-translational Modifications Using the MIScore.
    Kou Q; Zhu B; Wu S; Ansong C; Tolić N; Paša-Tolić L; Liu X
    J Proteome Res; 2016 Aug; 15(8):2422-32. PubMed ID: 27291504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constructing Human Proteoform Families Using Intact-Mass and Top-Down Proteomics with a Multi-Protease Global Post-Translational Modification Discovery Database.
    Dai Y; Buxton KE; Schaffer LV; Miller RM; Millikin RJ; Scalf M; Frey BL; Shortreed MR; Smith LM
    J Proteome Res; 2019 Oct; 18(10):3671-3680. PubMed ID: 31479276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Quantification of Murine Mitochondrial Proteoforms Using an Integrated Top-Down and Intact-Mass Strategy.
    Schaffer LV; Rensvold JW; Shortreed MR; Cesnik AJ; Jochem A; Scalf M; Frey BL; Pagliarini DJ; Smith LM
    J Proteome Res; 2018 Oct; 17(10):3526-3536. PubMed ID: 30180576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size Exclusion Chromatography Strategies and MASH Explorer for Large Proteoform Characterization.
    Tiambeng TN; Wu Z; Melby JA; Ge Y
    Methods Mol Biol; 2022; 2500():15-30. PubMed ID: 35657584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine Counting via Isotopic Chemical Labeling for Intact Mass Proteoform Identifications in Tissue.
    Pavek JG; Frey BL; Frost DC; Gu TJ; Li L; Smith LM
    Anal Chem; 2023 Oct; 95(41):15245-15253. PubMed ID: 37791746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of Human Proteoform Families from 21 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometry Top-Down Proteomic Data.
    Schaffer LV; Anderson LC; Butcher DS; Shortreed MR; Miller RM; Pavelec C; Smith LM
    J Proteome Res; 2021 Jan; 20(1):317-325. PubMed ID: 33074679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Intact Proteoform Characterization in Human Cell Lysate Using High-pH and Low-pH Reversed-Phase Liquid Chromatography.
    Yu D; Wang Z; Cupp-Sutton KA; Liu X; Wu S
    J Am Soc Mass Spectrom; 2019 Dec; 30(12):2502-2513. PubMed ID: 31755044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Value of Activated Ion Electron Transfer Dissociation for High-Throughput Top-Down Characterization of Intact Proteins.
    Riley NM; Sikora JW; Seckler HS; Greer JB; Fellers RT; LeDuc RD; Westphall MS; Thomas PM; Kelleher NL; Coon JJ
    Anal Chem; 2018 Jul; 90(14):8553-8560. PubMed ID: 29924586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the Separation Capacity of Intact Histone Proteoforms Chromatography Coupling Online Weak Cation Exchange-HILIC to Reversed Phase LC UVPD-HRMS.
    Gargano AFG; Shaw JB; Zhou M; Wilkins CS; Fillmore TL; Moore RJ; Somsen GW; Paša-Tolić L
    J Proteome Res; 2018 Nov; 17(11):3791-3800. PubMed ID: 30226781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary Zone Electrophoresis-Tandem Mass Spectrometry with Activated Ion Electron Transfer Dissociation for Large-scale Top-down Proteomics.
    McCool EN; Lodge JM; Basharat AR; Liu X; Coon JJ; Sun L
    J Am Soc Mass Spectrom; 2019 Dec; 30(12):2470-2479. PubMed ID: 31073891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridged Hybrid Monolithic Column Coupled to High-Resolution Mass Spectrometry for Top-Down Proteomics.
    Liang Y; Jin Y; Wu Z; Tucholski T; Brown KA; Zhang L; Zhang Y; Ge Y
    Anal Chem; 2019 Feb; 91(3):1743-1747. PubMed ID: 30668094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation and Identification of Thousands of Human Proteoforms below 30 kDa.
    Durbin KR; Fornelli L; Fellers RT; Doubleday PF; Narita M; Kelleher NL
    J Proteome Res; 2016 Mar; 15(3):976-82. PubMed ID: 26795204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput quantitative top-down proteomics.
    Cupp-Sutton KA; Wu S
    Mol Omics; 2020 Apr; 16(2):91-99. PubMed ID: 31932818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.